FDA Approves First Blood Test for Alzheimer's Disease in the US
The US has approved the first blood test for Alzheimer's, enabling earlier detection through a simple blood analysis that measures specific proteins linked to the disease, potentially transforming diagnosis and treatment.
In a groundbreaking development, the United States has approved the first blood test capable of detecting Alzheimer's disease, representing a significant advancement in early diagnosis and treatment. Developed by Fujirebio Diagnostics, this innovative test measures the ratio of two specific proteins in the bloodstream. This protein ratio correlates with amyloid plaques in the brain, which are characteristic of Alzheimer's. Traditionally, detecting these plaques involved brain scans or cerebrospinal fluid analysis, both of which are more invasive or expensive.
The significance of this blood test lies in its potential to make early diagnosis more accessible and less invasive. According to FDA Commissioner Marty Makary, Alzheimer's disease affects more individuals than breast and prostate cancers combined. With over 10% of those aged 65 and older affected, and estimates suggesting that this number could double by 2050, the anticipation is that such diagnostic tools could revolutionize patient care.
Currently, two treatments—lecanemab and donanemab—are FDA-approved and target amyloid plaques to modestly slow cognitive decline, although they do not cure the disease. Experts believe that starting treatment early, aided by reliable diagnostics like this blood test, could help preserve brain function longer and extend independence.
Clinical studies comparing this blood test to PET scans and cerebrospinal fluid tests have shown promising results, matching the accuracy of these more invasive methods. The FDA has authorized use of this test in clinical settings for patients showing signs of cognitive decline, emphasizing that results should be interpreted alongside other clinical information.
Alzheimer's is the most common form of dementia, gradually impairing memory and independence over time. The approval of this blood test marks an important step toward earlier detection, better treatment planning, and ultimately, improved patient outcomes.
Source: https://medicalxpress.com/news/2025-05-blood-alzheimer.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
The Urgent Need to Address Concussions and Chronic Traumatic Encephalopathy in Sports
Understanding and preventing chronic traumatic encephalopathy (CTE) is vital for athlete health. This article explores the risks, symptoms, and essential safety measures to protect sports players from long-term brain injuries.
The Science Behind Eye Color: Why Eyes Come in Blue, Green, Brown, and Everything In Between
Discover the fascinating science behind eye colors like blue, green, and brown, and learn how genetics and light influence this unique trait. Explore the biology, genetics, and interesting facts about human eye color diversity.
The Influence of Bedding on Sleep Thermal Comfort and Insulation
Explore how bedding and sleep posture influence thermal insulation and comfort during sleep. A recent study uses advanced modeling to optimize sleep environments for better health and comfort.
Social Discussions Among Close Friends Influence College Vaping Trends
A new study shows that peer conversations within close social groups significantly influence vaping behaviors among college students, highlighting the importance of peer-led prevention strategies.